Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes

Pooled Analysis of 39,505 Subjects

Masoor Kamalesh, Ton J. Cleophas

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Despite recent successes in improving mortality from congestive heart failure (CHF) with drugs and devices, several reports suggest increased mortality among CHF subjects with diabetes. Our objective was to conduct a meta-analysis to determine aggregate risk of mortality and hospitalization in CHF from systolic dysfunction and diabetes. Methods and Results: Observational and randomized trials reporting on CHF and mortality in diabetes since 2001 were identified through MEDLINE and Cochrane database searches and hand searching of cross-references. Minimum follow-up of the study cohort should have been at least 6 months. Studies with very small sample size (n < 200) were excluded. Major outcome measure of mortality and secondary outcome measure of CHF hospitalization were extracted from published results. Analysis was done for composite mortality and hospitalization risk, heterogeneity, robustness, and publication bias. A total of 17 trials (n = 39,505 subjects) were eligible. There were a total of 10,068 deaths, with 3615 among diabetics, from available data. The relative risk was significantly higher for diabetics by 28% (95% CI 1.22-1.34, P < .0001). Similarly pooled relative risk for hospitalization was significantly higher for diabetics by 36% (95% CI 1.26-1.48, P < .0001). Heterogeneity was present (P < .01) and accounted for by observational studies. There was no significant publication bias and lack of robustness was not obvious. Conclusions: Aggregate mortality and recurrent hospitalization risk for diabetic subjects with CHF is 28% and 36% higher than for nondiabetic subjects. Future trials should specifically focus on improving survival in these subjects.

Original languageEnglish
Pages (from-to)305-309
Number of pages5
JournalJournal of Cardiac Failure
Volume15
Issue number4
DOIs
StatePublished - May 2009

Fingerprint

Heart Failure
Mortality
Hospitalization
Publication Bias
Outcome Assessment (Health Care)
MEDLINE
Sample Size
Observational Studies
Meta-Analysis
Databases
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • Diabetes
  • heart failure
  • mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes : Pooled Analysis of 39,505 Subjects. / Kamalesh, Masoor; Cleophas, Ton J.

In: Journal of Cardiac Failure, Vol. 15, No. 4, 05.2009, p. 305-309.

Research output: Contribution to journalArticle

@article{3019d5dcc2e84503815eb509380cc69d,
title = "Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes: Pooled Analysis of 39,505 Subjects",
abstract = "Background: Despite recent successes in improving mortality from congestive heart failure (CHF) with drugs and devices, several reports suggest increased mortality among CHF subjects with diabetes. Our objective was to conduct a meta-analysis to determine aggregate risk of mortality and hospitalization in CHF from systolic dysfunction and diabetes. Methods and Results: Observational and randomized trials reporting on CHF and mortality in diabetes since 2001 were identified through MEDLINE and Cochrane database searches and hand searching of cross-references. Minimum follow-up of the study cohort should have been at least 6 months. Studies with very small sample size (n < 200) were excluded. Major outcome measure of mortality and secondary outcome measure of CHF hospitalization were extracted from published results. Analysis was done for composite mortality and hospitalization risk, heterogeneity, robustness, and publication bias. A total of 17 trials (n = 39,505 subjects) were eligible. There were a total of 10,068 deaths, with 3615 among diabetics, from available data. The relative risk was significantly higher for diabetics by 28{\%} (95{\%} CI 1.22-1.34, P < .0001). Similarly pooled relative risk for hospitalization was significantly higher for diabetics by 36{\%} (95{\%} CI 1.26-1.48, P < .0001). Heterogeneity was present (P < .01) and accounted for by observational studies. There was no significant publication bias and lack of robustness was not obvious. Conclusions: Aggregate mortality and recurrent hospitalization risk for diabetic subjects with CHF is 28{\%} and 36{\%} higher than for nondiabetic subjects. Future trials should specifically focus on improving survival in these subjects.",
keywords = "Diabetes, heart failure, mortality",
author = "Masoor Kamalesh and Cleophas, {Ton J.}",
year = "2009",
month = "5",
doi = "10.1016/j.cardfail.2008.11.006",
language = "English",
volume = "15",
pages = "305--309",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes

T2 - Pooled Analysis of 39,505 Subjects

AU - Kamalesh, Masoor

AU - Cleophas, Ton J.

PY - 2009/5

Y1 - 2009/5

N2 - Background: Despite recent successes in improving mortality from congestive heart failure (CHF) with drugs and devices, several reports suggest increased mortality among CHF subjects with diabetes. Our objective was to conduct a meta-analysis to determine aggregate risk of mortality and hospitalization in CHF from systolic dysfunction and diabetes. Methods and Results: Observational and randomized trials reporting on CHF and mortality in diabetes since 2001 were identified through MEDLINE and Cochrane database searches and hand searching of cross-references. Minimum follow-up of the study cohort should have been at least 6 months. Studies with very small sample size (n < 200) were excluded. Major outcome measure of mortality and secondary outcome measure of CHF hospitalization were extracted from published results. Analysis was done for composite mortality and hospitalization risk, heterogeneity, robustness, and publication bias. A total of 17 trials (n = 39,505 subjects) were eligible. There were a total of 10,068 deaths, with 3615 among diabetics, from available data. The relative risk was significantly higher for diabetics by 28% (95% CI 1.22-1.34, P < .0001). Similarly pooled relative risk for hospitalization was significantly higher for diabetics by 36% (95% CI 1.26-1.48, P < .0001). Heterogeneity was present (P < .01) and accounted for by observational studies. There was no significant publication bias and lack of robustness was not obvious. Conclusions: Aggregate mortality and recurrent hospitalization risk for diabetic subjects with CHF is 28% and 36% higher than for nondiabetic subjects. Future trials should specifically focus on improving survival in these subjects.

AB - Background: Despite recent successes in improving mortality from congestive heart failure (CHF) with drugs and devices, several reports suggest increased mortality among CHF subjects with diabetes. Our objective was to conduct a meta-analysis to determine aggregate risk of mortality and hospitalization in CHF from systolic dysfunction and diabetes. Methods and Results: Observational and randomized trials reporting on CHF and mortality in diabetes since 2001 were identified through MEDLINE and Cochrane database searches and hand searching of cross-references. Minimum follow-up of the study cohort should have been at least 6 months. Studies with very small sample size (n < 200) were excluded. Major outcome measure of mortality and secondary outcome measure of CHF hospitalization were extracted from published results. Analysis was done for composite mortality and hospitalization risk, heterogeneity, robustness, and publication bias. A total of 17 trials (n = 39,505 subjects) were eligible. There were a total of 10,068 deaths, with 3615 among diabetics, from available data. The relative risk was significantly higher for diabetics by 28% (95% CI 1.22-1.34, P < .0001). Similarly pooled relative risk for hospitalization was significantly higher for diabetics by 36% (95% CI 1.26-1.48, P < .0001). Heterogeneity was present (P < .01) and accounted for by observational studies. There was no significant publication bias and lack of robustness was not obvious. Conclusions: Aggregate mortality and recurrent hospitalization risk for diabetic subjects with CHF is 28% and 36% higher than for nondiabetic subjects. Future trials should specifically focus on improving survival in these subjects.

KW - Diabetes

KW - heart failure

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=65249170100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249170100&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2008.11.006

DO - 10.1016/j.cardfail.2008.11.006

M3 - Article

VL - 15

SP - 305

EP - 309

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 4

ER -